FDA Warning Letter — Prestige

Case 675375 — FEI 3030240789

The FDA took a Warning Letter action against Prestige on Jan 11, 2024 (Boston, MA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Prestige
Date
Jan 11, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Boston, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.